125 related articles for article (PubMed ID: 32323811)
1. Ropivacaine inhibits cervical cancer cell growth via suppression of the miR‑96/MEG2/pSTAT3 axis.
Chen X; Liu W; Guo X; Huang S; Song X
Oncol Rep; 2020 May; 43(5):1659-1668. PubMed ID: 32323811
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine phosphatase Meg2 dephosphorylates signal transducer and activator of transcription 3 and suppresses tumor growth in breast cancer.
Su F; Ren F; Rong Y; Wang Y; Geng Y; Wang Y; Feng M; Ju Y; Li Y; Zhao ZJ; Meng K; Chang Z
Breast Cancer Res; 2012 Mar; 14(2):R38. PubMed ID: 22394684
[TBL] [Abstract][Full Text] [Related]
3. Ropivacaine inhibits the proliferation and metastasis of gastric cancer cells via the SNX10/SRC/STAT3 pathway.
Deng RR; Yuan YP
Chem Biol Drug Des; 2024 Jan; 103(1):e14405. PubMed ID: 37989501
[TBL] [Abstract][Full Text] [Related]
4. Growth arrest-specific 5 attenuates cisplatin-induced apoptosis in cervical cancer by regulating STAT3 signaling via miR-21.
Yao T; Lu R; Zhang J; Fang X; Fan L; Huang C; Lin R; Lin Z
J Cell Physiol; 2019 Jun; 234(6):9605-9615. PubMed ID: 30352127
[TBL] [Abstract][Full Text] [Related]
5. The Critical Role of the miR-21-MEG2 Axis in Colorectal Cancer.
Bao Z; Gao S; Zhang B; Shi W; Li A; Tian Q
Crit Rev Eukaryot Gene Expr; 2020; 30(6):509-518. PubMed ID: 33463918
[TBL] [Abstract][Full Text] [Related]
6. Methyllucidone inhibits STAT3 activity by regulating the expression of the protein tyrosine phosphatase MEG2 in DU145 prostate carcinoma cells.
Jin Y; Kim YH; Park JY; Lee YJ; Oh HM; Choi SK; Han DC; Kwon BM
Bioorg Med Chem Lett; 2018 Mar; 28(5):853-857. PubMed ID: 29456111
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-mediated miR-29b expression inhibits the invasion and angiogenesis of cervical cancer.
Li Y; Zhang Z; Xiao Z; Lin Y; Luo T; Zhou Q; Zhang X
Oncotarget; 2017 Feb; 8(9):14655-14665. PubMed ID: 28122338
[TBL] [Abstract][Full Text] [Related]
8. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
[TBL] [Abstract][Full Text] [Related]
9. GRIM‑19‑mediated Stat3 activation is a determinant for resveratrol‑induced proliferation and cytotoxicity in cervical tumor‑derived cell lines.
Li YG; Xia HJ; Tao JP; Xin P; Liu MY; Li JB; Zhu W; Wei M
Mol Med Rep; 2015 Feb; 11(2):1272-7. PubMed ID: 25351437
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA SNHG12 promotes the progression of cervical cancer via modulating miR-125b/STAT3 axis.
Jin XJ; Chen XJ; Zhang ZF; Hu WS; Ou RY; Li S; Xue JS; Chen LL; Hu Y; Zhu H
J Cell Physiol; 2019 May; 234(5):6624-6632. PubMed ID: 30246459
[TBL] [Abstract][Full Text] [Related]
11. Stat3 activation in human endometrial and cervical cancers.
Chen CL; Hsieh FC; Lieblein JC; Brown J; Chan C; Wallace JA; Cheng G; Hall BM; Lin J
Br J Cancer; 2007 Feb; 96(4):591-9. PubMed ID: 17311011
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-411 Inhibits Cervical Cancer Progression by Directly Targeting STAT3.
Shan D; Shang Y; Hu T
Oncol Res; 2019 Feb; 27(3):349-358. PubMed ID: 29716674
[TBL] [Abstract][Full Text] [Related]
13. Natural killer T cell cytotoxic activity in cervical cancer is facilitated by the LINC00240/microRNA-124-3p/STAT3/MICA axis.
Zhang Y; Li X; Zhang J; Liang H
Cancer Lett; 2020 Apr; 474():63-73. PubMed ID: 31904481
[TBL] [Abstract][Full Text] [Related]
14. Paeoniflorin inhibits human gastric carcinoma cell proliferation through up-regulation of microRNA-124 and suppression of PI3K/Akt and STAT3 signaling.
Zheng YB; Xiao GC; Tong SL; Ding Y; Wang QS; Li SB; Hao ZN
World J Gastroenterol; 2015 Jun; 21(23):7197-207. PubMed ID: 26109806
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of protease-activated receptor-2 induces apoptosis in cervical cancer by inhibiting signal transducer and activator of transcription-3 signaling.
Shanshan H; Lan X; Xia L; Huang W; Meifang Z; Ling Y
J Int Med Res; 2019 Mar; 47(3):1330-1338. PubMed ID: 30700181
[TBL] [Abstract][Full Text] [Related]
16. Sugiol inhibits STAT3 activity via regulation of transketolase and ROS-mediated ERK activation in DU145 prostate carcinoma cells.
Jung SN; Shin DS; Kim HN; Jeon YJ; Yun J; Lee YJ; Kang JS; Han DC; Kwon BM
Biochem Pharmacol; 2015 Sep; 97(1):38-50. PubMed ID: 26212545
[TBL] [Abstract][Full Text] [Related]
17. MEG2 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting AKT pathway.
Ying D; Ruan Y; Zhou X
Gene; 2019 Mar; 687():1-8. PubMed ID: 30399427
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein.
Shishodia G; Verma G; Srivastava Y; Mehrotra R; Das BC; Bharti AC
BMC Cancer; 2014 Dec; 14():996. PubMed ID: 25539644
[TBL] [Abstract][Full Text] [Related]
19. miR‑96 exerts an oncogenic role in the progression of cervical cancer by targeting CAV‑1.
Chen Y; Liu C; Xie B; Chen S; Zhuang Y; Zhang S
Mol Med Rep; 2020 Jul; 22(1):543-550. PubMed ID: 32377722
[TBL] [Abstract][Full Text] [Related]
20. MUC16 facilitates cervical cancer progression via JAK2/STAT3 phosphorylation-mediated cyclooxygenase-2 expression.
Shen H; Guo M; Wang L; Cui X
Genes Genomics; 2020 Feb; 42(2):127-133. PubMed ID: 31736008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
